Theranica and Dr. Reddy's Collaborate on Marketing Initiative for Nerivio® in the European Region

Wednesday, November 15, 2023

Theranica and Dr. Reddy's Laboratories Ltd. have jointly announced an exclusive partnership for the distribution and marketing of Nerivio®, a novel drug-free Remote Electrical Neuromodulation (REN) wearable device designed for migraine treatment. The collaboration encompasses multiple European countries, including Austria, Czech Republic, Denmark, Finland, France, Italy, Norway, Poland, Slovakia, Spain, Sweden, Switzerland, the United Kingdom, and Germany, the latter being part of a previous agreement.

Nerivio® has recently obtained an expanded CE Mark approval under the European Medical Device Regulation (MDR), endorsing its use for both acute and preventive migraine treatment in adults and adolescents.

The commercial agreement involves licensing fees and additional payments, granting Dr. Reddy's exclusive rights for the marketing of Nerivio® in the specified European regions. Dr. Reddy's subsidiaries will oversee marketing, sales, and local support for Nerivio®, starting in Germany and gradually expanding across the mentioned European countries.

This collaboration marks a significant development in addressing the needs of the vast number of migraine sufferers in Europe, a population that includes millions of adolescents and young adults. Migraine stands as a leading cause of disability globally, necessitating early intervention with both preventive and acute treatments to mitigate the potential exacerbation of the condition in adulthood.

The partnership builds on a prior agreement between Theranica and Dr. Reddy's for the commercial collaboration of Nerivio® in India, underscoring the companies' dedication to meeting unmet patient needs, particularly among underserved populations like adolescents experiencing migraines.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024